(Q35594930)

English

Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial

scientific article published on September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial (English)

1 reference

Europe PubMed Central

9 August 2017

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

J Labenz

1

1 reference

Europe PubMed Central

9 August 2017

A L Blum

2

1 reference

Europe PubMed Central

9 August 2017

W W Bolten

3

1 reference

Europe PubMed Central

9 August 2017

B Dragosics

4

1 reference

Europe PubMed Central

9 August 2017

W Rösch

5

1 reference

Europe PubMed Central

9 August 2017

M Stolte

6

1 reference

Europe PubMed Central

9 August 2017

H R Koelz

7

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

51

1 reference

Europe PubMed Central

9 August 2017

3

1 reference

Europe PubMed Central

9 August 2017

329-335

1 reference

Europe PubMed Central

9 August 2017

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Confidence intervals for the number needed to treat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Does Helicobacter pylori status affect nonsteroidal anti-inflammatory drug-associated gastroduodenal pathology?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

What's wrong with Bonferroni adjustments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Epidemiology and genetics of peptic ulcer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

12 July 2018

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

26 September 2018

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

26 September 2018

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

26 September 2018

Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1773346

26 September 2018

Dyspepsia in healthy blood donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiologic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of a novel biopsy urease test (HUT) and a simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-steroidal anti-inflammatory drugs inhibit Helicobacter pylori-induced human neutrophil reactive oxygen metabolite production in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of Helicobacter pylori eradication and non-steroidal anti-inflammatory drugs on gastric epithelial apoptosis and proliferation: implications on ulcerogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/12171952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.51.3.329

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35594930&oldid=1586474376"